Authors: RANCHERE JY DELFOSSE MH SALTEL P LATOUR JF

Citation: Jy. Ranchere et al., MORPHINIC THERAPY - ASSESSMENT OF PATIENT S INFORMATION, Bulletin du cancer, 85(4), 1998, pp. 353-357

Authors: RANCHERE JY LATOUR JF FUHRMANN C LAGALLARDE C LOREUIL F

Citation: Jy. Ranchere et al., AMPHOTERICIN-B INTRALIPID FORMULATION - STABILITY AND PARTICLE, Journal of antimicrobial chemotherapy, 37(6), 1996, pp. 1165-1169

Authors: CRAUSTEMANCIET S FAURE P LATOUR JF MADELAINECHAMBRIN I SAULNIER JL

Citation: S. Craustemanciet et al., STANDARDS, OPTIONS AND GUIDELINES FOR THE USE OF ANTICANCER AGENTS, Bulletin du cancer, 82, 1995, pp. 320-452

Authors: BLAY JY FERVERS B LATOUR JF PHILIP T

Citation: Jy. Blay et al., STANDARDS, OPTIONS AND GUIDELINES FOR THE USE OF HEMATOPOIETIC GROWTH-FACTORS IN ONCOLOGY, Bulletin du cancer, 82, 1995, pp. 487-508

Authors: HERON JF FERVERS B LATOUR JF SOMMELET D CHAUVERGNE J PHILIP T

Citation: Jf. Heron et al., STANDARDS, OPTIONS AND GUIDELINES FOR APP LICATIONS IN CHEMOTHERAPY, Bulletin du cancer, 82(10), 1995, pp. 823-834